Position in EBS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,757,522
+$2,535,224 QoQ
Shares Held
329,060
+5977.9% QoQ
Ownership
0.642%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 56 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $63,074,679 across 13 Drug Manufacturers - Specialty & Generic names. EBS ranks #4 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
765,543 | $40,114,453 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
443,647 | $7,679,529 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
216,960 | $5,339,385 | |
| 4 | EBS |
Emergent BioSolutions Inc.
This page
|
329,060 | $2,757,522 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
227,579 | $1,802,425 | |
| 6 | ZTS |
Zoetis Inc.
|
22,499 | $1,616,778 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,880 | $1,560,470 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,763 | $635,690 |
All Filings in EBS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,757,522 | 329,060 | Shares | Sole | 2026-08-06 | |
| 2022-03-31 | $222,298 | 5,414 | Shares | Sole | 2022-05-12 | |
| 2021-06-30 | $1,952 | 31 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $84,455 | 909 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $486,080 | 5,425 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,952,551 | 28,574 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $141,236 | 1,786 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $36,567 | 632 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||